InSignia
- Health
SpeeDx Receives CARB-X Funding to Develop Rapid Point-of-Care Diagnostic
Sydney, Australia: SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, announced it has been awarded up to US…
Read More » - World
SpeeDx Partners with Nepean Hospital to Commercialise Respiratory Virus Host Biomarker Assay
SpeeDx newly patented InSignia technology simplifies the measurement of gene expression and will underpin the creation of a simple, standardized…
Read More » - Health
SpeeDx and Nepean Hospital Awarded Federal Funding for Viral Respiratory Biomarker Test
Utilising newly patented InSignia(TM) technology that enhances the measurement of gene expression, the test will be a rapid, high-throughput tool…
Read More »